So, the Marketplace Fairness Act. Ben Domenech and Francis Cianfrocca recently went off on it on Coffee and Markets, which is a great series to listen to. Having an opportunity to block out time to listen to it is probably the best part of having a 2.5 hour commute from Arlington to Purcellville (and then 2.5 hours back). I support the bill, and the interstate | Read More »
Most transparent administration EVAR, my eye: A wide-ranging surveillance operation by the Food and Drug Administration against a group of its own scientists used an enemies list of sorts as it secretly captured thousands of e-mails that the disgruntled scientists sent privately to members of Congress, lawyers, labor officials, journalists and even President Obama, previously undisclosed records show. What began as a narrow investigation into | Read More »
With a looming fight over raising the debt limit and how to get a handle on our $14 trillion debt, there is one issue that keeps popping up in Congress as a blatant example of government redundancy and pure waste: catfish inspection. Yes, you read correctly. There is a brewing fight over the regulation of catfish. Special interest groups slipped language into a bill that | Read More »
Download Podcast | iTunes | Podcast Feed On today’s edition of Coffee and Markets, Brad Jackson and Ben Domenech are joined by Benjamin Zycher to discuss Obamacare, the FDA and the importance of competition in health care, then Pejman Yousefzadeh talks about Mitch Daniels and CPAC. We’re brought to you as always by BigGovernment and Stephen Clouse and Associates. If you’d like to email us, | Read More »
You probably remember the fanatical fear that gripped the nation these last few years in response to a few factories with tainted peanut butter. You may also remember the national panic when spinach was a killer stalking grocery stores across the country. These types of events are notorious for being blown out of proportion by the national media & being chaotic by virtue of bureaucratic | Read More »
Obamacare created a new Independent Medicare Advisory Board (IMAB) to ‘curtail spending’. Now, on advice from the IMAB, the FDA is considering restricting Avastin. It is amazing to see the range of responses from the left here in America.
Until recently, the implications of ObamaCare were debated in a vacuum. There were allegations and responses, but no results to support either side. Now that we have entered the implementation phase of ObamaCare, things are becoming more clear. Many of the bold promises that were offered to sell ObamaCare to the American public were not based in reality. Taxes increases hit Americans next year and, in many | Read More »
This article (H/T: The New Ledger) says absolutely everything that you need to know about the messianic zealots assailing the Food and Drug Administration right now. Quick context: somebody in North Carolina (quick, North Carolinian voters: how does your legislator feel about wrecking the taste of your bacon?) noticed that the FDA is gearing up a set of rules on sodium levels that might have | Read More »
![[RS]](/t/img/logo-footer.jpg){kind=logo}